CTP-499

Concert Pharmaceuticals' Shares Slip Despite Favorable FDA Meeting
Yahoo/Zacks.com
Wed, 07/9/14 - 11:50 am
Concert Pharmaceuticals
FDA
CTP-499
diabetic nephropathy